Figure 4.

Pax2 predicts clinical outcome in breast cancer patients. Kaplan-Meier curve representing percent relapse free survival in tumours based on Pax2 and AIB-1 staining (n = 109). The percentage of ErbB2 over-expressing tumours within each category is provided.